Healthcare provider profile · identity verified

Marco Maldonado

Family Practice · LOVINGTON, NM · NPI 1144603408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	151
Metformin Hcl	Metformin Hcl	310	88
Levothyroxine Sodium	Levothyroxine Sodium	277	75
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	258	40
Omeprazole	Omeprazole	212	68
Amlodipine Besylate	Amlodipine Besylate	210	77
Lisinopril	Lisinopril	209	71
Trulicity	Dulaglutide	200	23
Gabapentin	Gabapentin	169	49
Losartan Potassium	Losartan Potassium	132	46
Potassium Chloride	Potassium Chloride	132	43
Glipizide	Glipizide	126	42
Valsartan	Valsartan	119	33
Alprazolam	Alprazolam	111	37
Albuterol Sulfate Hfa	Albuterol Sulfate	105	29
Furosemide	Furosemide	103	34
Zolpidem Tartrate	Zolpidem Tartrate	101	26
Alendronate Sodium	Alendronate Sodium	98	31
Hydrochlorothiazide	Hydrochlorothiazide	96	29
Diclofenac Sodium	Diclofenac Sodium	94	34
Pantoprazole Sodium	Pantoprazole Sodium	94	29
Tamsulosin Hcl	Tamsulosin Hcl	93	31
Januvia	Sitagliptin Phosphate	90	19
Clopidogrel	Clopidogrel Bisulfate	80	25
Metoprolol Succinate	Metoprolol Succinate	78	25
Tramadol Hcl	Tramadol Hcl	78	25
Simvastatin	Simvastatin	72	23
Sertraline Hcl	Sertraline Hcl	70	20
Dexamethasone	Dexamethasone	66	43
Glipizide Er	Glipizide	64	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	18
Pioglitazone Hcl	Pioglitazone Hcl	64	16
Meloxicam	Meloxicam	61	19
Baclofen	Baclofen	60	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	16
Metoprolol Tartrate	Metoprolol Tartrate	59	17
Ibuprofen	Ibuprofen	58	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	suppressed
Trazodone Hcl	Trazodone Hcl	56	15
Rosuvastatin Calcium	Rosuvastatin Calcium	55	17
Chlorthalidone	Chlorthalidone	54	15
Carisoprodol	Carisoprodol	53	suppressed
Glimepiride	Glimepiride	52	14
Eliquis	Apixaban	50	13
Fluoxetine Hcl	Fluoxetine Hcl	49	19
Allopurinol	Allopurinol	48	16
Benazepril Hcl	Benazepril Hcl	48	13
Farxiga	Dapagliflozin Propanediol	47	suppressed
Jardiance	Empagliflozin	47	11
Metformin Hcl Er	Metformin Hcl	46	19
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Tresiba Flextouch U-100	Insulin Degludec	45	12
Carvedilol	Carvedilol	44	17
Famotidine	Famotidine	44	12
Mounjaro	Tirzepatide	44	suppressed
Fluconazole	Fluconazole	42	19
Spironolactone	Spironolactone	41	14
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Montelukast Sodium	Montelukast Sodium	40	14
Atenolol	Atenolol	38	15
Bupropion Xl	Bupropion Hcl	37	11
Doxycycline Hyclate	Doxycycline Hyclate	36	30
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Celecoxib	Celecoxib	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Nystatin	Nystatin	33	15
Pregabalin	Pregabalin	33	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	11
Jentadueto	Linagliptin/Metformin Hcl	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Citalopram Hbr	Citalopram Hydrobromide	28	14
Ozempic	Semaglutide	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Finasteride	Finasteride	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	15
Duloxetine Hcl	Duloxetine Hcl	22	11
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Naproxen	Naproxen	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	21	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Lactulose	Lactulose	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nayzilam	Midazolam	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Movantik	Naloxegol Oxalate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Methocarbamol	Methocarbamol	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Temazepam	Temazepam	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error